Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on September 13, 2016. The filing serves as a Regulation FD disclosure regarding upcoming communications with securities analysts and investors scheduled between September 13, 2016, and September 30, 2016.
Key Financial Metrics and Guidance
The filing does not report historical financial results for a specific period but provides reaffirmed full-year 2016 guidance:
- Net Income Guidance: Greater than $9.34 per share.
- Unfavorable Items: The net income guidance includes greater than $1.46 per share of net unfavorable items.
- Adjusted Net Income: Excluding unfavorable items, the company expects adjusted net income to be greater than $10.80 per share.
- Adjustment Scope: This guidance does not include any adjustment items beyond those reported in the second quarter 2016 earnings release.
The filing text does not provide clear values for revenue, cash flow, margins, debt, or liquidity metrics.
Material Changes and Outlook
Management intends to reaffirm the previously issued full-year 2016 net income guidance during the upcoming investor meetings. No material changes to the financial outlook were announced in this specific filing beyond the reaffirmation of existing targets.
Risks, Contingencies, and Unusual Items
The document contains extensive forward-looking statements subject to significant risks and uncertainties, including:
- Pending Acquisition: Risks associated with the ultimate outcome of the acquisition of Cigna Corporation, including regulatory approval, integration challenges, and the ability to achieve synergies.
- Regulatory Environment: Impact of the Patient Protection and Affordable Care Act, health care reform, and government participation in managed care.
- Operational Risks: Trends in health care costs, premium rate adequacy, provider contracting, and enrollment changes.
- Cybersecurity: Ongoing risks related to the cyber-attack reported in February 2015, including investigations and litigation.
- Financial Risks: Potential impairment of intangible assets, litigation costs, and the impact of substantial outstanding indebtedness.
Investor Verification Checklist
- Verify the final full-year 2016 net income per share against the reaffirmed guidance of >$9.34.
- Confirm the status and regulatory approval of the pending Cigna Corporation acquisition.
- Review the specific nature and magnitude of the >$1.46 per share in net unfavorable items referenced in the guidance.
- Monitor updates regarding the February 2015 cyber-attack and associated legal or financial liabilities.
- Assess the impact of health care reform regulations on premium rates and enrollment in Individual and Small Group markets.